OTAVAchemicals and Institute of Genetics and Molecular Medicine at University of Edinburgh Announce Research Collaboration
29th of February 2008 – OTAVAchemicals, a leading Canadian company that specializes in drug discovery technologies, and Institute of Genetics and Molecular Medicine at University of Edinburgh, Cancer Research UK-p53 Signal Transduction Laboratories (UK), have announced plans for an integrated research project focused on a kinase targets.
In terms of the project, OTAVAchemicals will perform virtual screening to identify a set of compounds that might display protein kinase inhibitory activity. In addition, OTAVAchemicals scientists will carry out all tasks associated with organic synthesis and chemical optimization.
Scientists from Cancer Research UK-p53 Signal Transduction Laboratories are responsible for biological in vitro tests concerning determination of the kinase inhibitory activity of selected compounds including enzymatic assays and cell tests.
OTAVAchemicals supplies fine organic chemicals including unique building blocks for combinatorial organic synthesis. We provide compound libraries for screening, custom synthesis, molecular modeling services, targeted compound libraries and protein kinase inhibitors, prescreened anticancer compounds, peptide and chromogenic substrates. We offer design and development of fluorescent probes, kits and reagents.
About Institute of Genetics and Molecular Medicine at University of Edinburgh:
Institute of Genetics and Molecular Medicine at University of Edinburgh (Cancer Research UK-p53 Signal Transduction Laboratories) is a translational research centre that strive for excellence in basic science research and seek to bridge from the laboratory to the clinic and back again. It is outward looking and interdisciplinary: principle investigators comprise biochemists, geneticists, oncologists, chemists, pathologists, psychiatrists, surgeons, family practitioners, palliative medicine specialists, cell biologists. There are extensive local collaborative links particularly to the Medical Research Council Human Genetics Unit, and also external collaborators.
65 Ellerslie Ave., Suite 560
Toronto, Ontario, M2N 1Y1
Institute of Genetics and Molecular Medicine
University of Edinburgh
South Crewe Road
Edinburgh, United Kingdom